Who is sponsoring NCT03121898?

NCT03121898 is sponsored by IRCCS Policlinico S. Donato.

What drugs are being tested in NCT03121898?

Interventions in NCT03121898: Platelet function test.

What condition does NCT03121898 study?

NCT03121898 studies Platelet Dysfunction Due to Drugs, Bleeding.

Is NCT03121898 still recruiting?

NCT03121898 is currently completed. Last updated 22 June 2020.

Last reviewed 2020-06-22 · How we verify

NCT03121898: PLATFORM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PLATelet Function Operating Room Monitoring

Completed Last updated 22 June 2020

What this trial tests

trial testing Platelet function test in Platelet Dysfunction Due to Drugs in 490 participants. Completed in 31 March 2018.

Timeline

1 February 2017

Primary endpoint
31 January 2018

31 March 2018

Quick facts

Lead sponsor	IRCCS Policlinico S. Donato
Status	Completed
Study type	OBSERVATIONAL
Enrollment	490
Start date	1 February 2017
Primary completion	31 January 2018
Estimated completion	31 March 2018
Sites	1 location across Italy

Drugs / interventions tested

Platelet function test

Conditions studied

Platelet Dysfunction Due to Drugs — all drugs for Platelet Dysfunction Due to Drugs →
Bleeding — all drugs for Bleeding →

Sponsor

IRCCS Policlinico S. Donato

Who can join

Adults 18 to 95, any sex, with Platelet Dysfunction Due to Drugs or Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective cohort study on adult cardiac surgery patients. Platelet function evaluated before and after cardiopulmonary bypass. Bleeding and transfusion recorded. Primary endpoint is finding the association between postoperative platelet function and bleeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet function test

Trials testing the same drug.

NCT03679858 — Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls · unknown

Other IRCCS Policlinico S. Donato trials

Trials by the same sponsor.

NCT07295522 — Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? · Phase 4 · not yet recruiting
NCT07169669 — Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome · not yet recruiting
NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07402161 — The Signature of Alzheimer's Disease in Subjective Cognitive Decline · recruiting
NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03121898 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS Policlinico S. Donato
Last refreshed: 22 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03121898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing